1. Home
  2. EPSN vs CRBP Comparison

EPSN vs CRBP Comparison

Compare EPSN & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Epsilon Energy Ltd.

EPSN

Epsilon Energy Ltd.

HOLD

Current Price

$5.21

Market Cap

187.2M

Sector

Energy

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$8.31

Market Cap

184.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPSN
CRBP
Founded
2005
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.2M
184.4M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
EPSN
CRBP
Price
$5.21
$8.31
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$45.50
AVG Volume (30 Days)
138.9K
725.3K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
4.01%
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
N/A
$4,822,272.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$116.00
P/E Ratio
$265.00
N/A
Revenue Growth
N/A
97.62
52 Week Low
$4.20
$6.73
52 Week High
$8.08
$20.56

Technical Indicators

Market Signals
Indicator
EPSN
CRBP
Relative Strength Index (RSI) 34.04 47.33
Support Level $4.62 $8.04
Resistance Level $5.96 $8.54
Average True Range (ATR) 0.21 0.46
MACD -0.06 0.13
Stochastic Oscillator 7.66 81.33

Price Performance

Historical Comparison
EPSN
CRBP

About EPSN Epsilon Energy Ltd.

Epsilon Energy Ltd is a North American on-shore focused independent natural gas and oil company engaged in the acquisition, development, gathering and production of natural gas and oil reserves. Its properties include Appalachian Basin-Pennsylvania, Permian Basin-Texas and New Mexico, Anadarko Basin-Oklahoma, Powder River Basin-Wyoming, Western Canadian Sedimentary Basin-Alberta, Canada. Its segments include The Upstream segment activities include acquisition, development and production of natural gas and oil reserves on properties within the United States and Canada; and The Gas Gathering segment partners with two other companies to operate a natural gas gathering system. The Upstream segment derives the majority of the revenue.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: